常春藤治療公司
US ˙ NasdaqCM ˙ US92790C1045

簡介

本頁面提供了有關 Kyle Lefkoff 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Kyle Lefkoff已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:04269XAA3 / Array BioPharma Inc. Bonds 3.0% 6/1/2020 Director 0
US:VRDN / Viridian Therapeutics, Inc. Director 12,000
US:RALY / Rally Software Development Corp 10% Owner 225,008
US:ABIO / ARCA biopharma, Inc. 10% Owner 549
如何解讀這些圖表

以下圖表顯示了在Kyle Lefkoff進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

VRDN / Viridian Therapeutics, Inc.內部人士買入 - 短期收益分析

在這一部分,我們分析了在 VRDN / Viridian Therapeutics, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

VRDN / Viridian Therapeutics, Inc. Insider Trades
VRDN / Viridian Therapeutics, Inc.內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 VRDN / Viridian Therapeutics, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
2017-03-10 MGEN LEFKOFF KYLE 3,300 14.3118 220 214.6770 47,229 336 5.3800 -46,044 -97.49
2017-03-09 MGEN LEFKOFF KYLE 2,500 14.3846 167 215.7690 35,962
2017-03-08 MGEN LEFKOFF KYLE 5,000 14.7028 333 220.5420 73,514
2017-03-06 MGEN LEFKOFF KYLE 9,392 15.7144 626 235.7160 147,590
2017-03-06 MGEN LEFKOFF KYLE 608 16.2398 41 243.5970 9,874
2017-02-28 MGEN LEFKOFF KYLE 2,258 13.5430 151 203.1450 30,580
2017-02-27 MGEN LEFKOFF KYLE 1,500 13.7910 100 206.8650 20,686
2017-02-24 MGEN LEFKOFF KYLE 6,500 14.0388 433 210.5820 91,252
2017-02-23 MGEN LEFKOFF KYLE 1,800 13.6477 120 204.7155 24,566
2017-02-22 MGEN LEFKOFF KYLE 4,102 14.3554 273 215.3310 58,886

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

VRDN / Viridian Therapeutics, Inc. Insider Trades
歷史內部人交易

該表格顯示了由 Kyle Lefkoff 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2019-07-30 2019-07-30 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
D - Sale to Issuer -25,000 0 -100.00
2019-07-30 2019-07-30 4 ARRY ARRAY BIOPHARMA INC
Common Stock
D - Sale to Issuer -30,000 0 -100.00 48.00 -1,440,000
2019-07-30 2019-07-30 4 ARRY ARRAY BIOPHARMA INC
Common Stock
U - Other -15,000 30,000 -33.33 48.00 -720,000 1,440,000
2019-07-30 2019-07-30 4 ARRY ARRAY BIOPHARMA INC
Common Stock
U - Other -20,000 45,000 -30.77 48.00 -960,000 2,160,000
2019-07-30 2019-07-30 4 ARRY ARRAY BIOPHARMA INC
Common Stock
D - Sale to Issuer -5,000 65,000 -7.14
2019-07-30 2019-07-30 4 ARRY ARRAY BIOPHARMA INC
Common Stock
D - Sale to Issuer -85 70,000 -0.12 48.00 -4,080 3,360,000
2019-07-30 2019-07-30 4 ARRY ARRAY BIOPHARMA INC
Common Stock
U - Other -22,635 70,085 -24.41 48.00 -1,086,480 3,364,080
2019-02-08 2019-02-06 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
M - Exercise -25,000 0 -100.00
2019-02-08 2019-02-06 4 ARRY ARRAY BIOPHARMA INC
Common Stock
S - Sale -5,000 20,000 -20.00 20.85 -104,261 417,044
2019-02-08 2019-02-06 4 ARRY ARRAY BIOPHARMA INC
Common Stock
S - Sale -5,000 25,000 -16.67 20.82 -104,120 520,602
2019-02-08 2019-02-06 4 ARRY ARRAY BIOPHARMA INC
Common Stock
S - Sale -25,000 22,720 -52.39 20.51 -512,692 465,935
2019-02-08 2019-02-06 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise 25,000 47,720 110.04 10.47 261,750 499,628
2018-10-29 2018-10-26 4 ARRY ARRAY BIOPHARMA INC
Restricted Stock Units
M - Exercise -5,000 0 -100.00
2018-10-29 2018-10-26 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise 5,000 22,720 28.22
2018-10-29 2018-10-25 4 ARRY ARRAY BIOPHARMA INC
Restricted Stock Units
A - Award 5,000 5,000
2018-10-29 2018-10-25 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
A - Award 25,000 25,000
2018-08-17 2016-11-28 4/A ARRY ARRAY BIOPHARMA INC
Common Stock
G - Gift -2,085 6,500 -24.29
2018-07-06 2018-07-06 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
M - Exercise -25,000 0 -100.00
2018-07-06 2018-07-06 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
M - Exercise -25,000 0 -100.00
2018-07-06 2018-07-06 4 ARRY ARRAY BIOPHARMA INC
Common Stock
S - Sale -50,000 17,720 -73.83 17.45 -872,500 309,214
2018-07-06 2018-07-06 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise 25,000 67,720 58.52 5.95 148,750 402,934
2018-07-06 2018-07-06 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise 25,000 42,720 141.08 5.13 128,250 219,154
2018-02-12 2018-02-09 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
M - Exercise -25,000 0 -100.00
2018-02-12 2018-02-09 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
M - Exercise -25,000 0 -100.00
2018-02-12 2018-02-09 4 ARRY ARRAY BIOPHARMA INC
Common Stock
S - Sale -50,000 17,720 -73.83 17.01 -850,500 301,417
2018-02-12 2018-02-09 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise 25,000 67,720 58.52 3.87 96,750 262,076
2018-02-12 2018-02-09 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise 25,000 42,720 141.08 5.60 140,000 239,232
2017-10-27 2017-10-27 4 ARRY ARRAY BIOPHARMA INC
Restricted Stock Units
M - Exercise -5,000 0 -100.00
2017-10-27 2017-10-27 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise 5,000 17,720 39.31 10.47 52,350 185,528
2017-10-27 2017-10-26 4 ARRY ARRAY BIOPHARMA INC
Restricted Stock Units
A - Award 5,000 5,000
2017-10-27 2017-10-26 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
A - Award 25,000 25,000
2017-09-29 2017-09-29 4 ARRY ARRAY BIOPHARMA INC
Stock Option
M - Exercise -45,000 0 -100.00
2017-09-29 2017-09-29 4 ARRY ARRAY BIOPHARMA INC
Common Stock
S - Sale -38,865 12,720 -75.34 12.31 -478,428 156,583
2017-09-29 2017-09-29 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise 45,000 51,585 683.37 10.58 476,100 545,769
2017-06-30 2017-06-28 4 MGEN MIRAGEN THERAPEUTICS, INC.
Stock Option (right to buy)
A - Award 12,000 12,000
2017-04-04 2017-03-31 4 ARRY ARRAY BIOPHARMA INC
Stock Option
M - Exercise -20,000 0 -100.00
2017-04-04 2017-03-31 4 ARRY ARRAY BIOPHARMA INC
Stock Option
M - Exercise -25,000 0 -100.00
2017-04-04 2017-03-31 4 ARRY ARRAY BIOPHARMA INC
Common Stock
S - Sale -45,000 6,585 -87.23 8.92 -401,400 58,738
2017-04-04 2017-03-31 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise 20,000 51,585 63.32 4.36 87,200 224,911
2017-04-04 2017-03-31 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise 25,000 31,585 379.65 3.69 92,250 116,549
2017-04-04 2016-11-28 4 ARRY ARRAY BIOPHARMA INC
Common Stock
G - Gift -2,000 6,585 -23.30
2017-03-13 2017-03-10 4 MGEN MIRAGEN THERAPEUTICS, INC.
Common Stock
S - Sale -3,300 463,473 -0.71 14.31 -47,229 6,633,133
2017-03-13 2017-03-09 4 MGEN MIRAGEN THERAPEUTICS, INC.
Common Stock
S - Sale -2,500 466,773 -0.53 14.38 -35,962 6,714,343
2017-03-08 2017-03-08 4 MGEN MIRAGEN THERAPEUTICS, INC.
Common Stock
S - Sale -5,000 469,273 -1.05 14.70 -73,514 6,899,627
2017-03-08 2017-03-06 4 MGEN MIRAGEN THERAPEUTICS, INC.
Common Stock
S - Sale -608 474,273 -0.13 16.24 -9,874 7,702,099
2017-03-08 2017-03-06 4 MGEN MIRAGEN THERAPEUTICS, INC.
Common Stock
S - Sale -9,392 474,881 -1.94 15.71 -147,590 7,462,470
2017-02-28 2017-02-28 4 MGEN MIRAGEN THERAPEUTICS, INC.
Common Stock
S - Sale -2,258 484,273 -0.46 13.54 -30,580 6,558,509
2017-02-28 2017-02-27 4 MGEN MIRAGEN THERAPEUTICS, INC.
Common Stock
S - Sale -1,500 486,531 -0.31 13.79 -20,686 6,709,749
2017-02-28 2017-02-24 4 MGEN MIRAGEN THERAPEUTICS, INC.
Common Stock
S - Sale -6,500 488,031 -1.31 14.04 -91,252 6,851,370
2017-02-24 2017-02-23 4 MGEN MIRAGEN THERAPEUTICS, INC.
Common Stock
S - Sale -1,800 494,531 -0.36 13.65 -24,566 6,749,211
2017-02-24 2017-02-22 4 MGEN MIRAGEN THERAPEUTICS, INC.
Common Stock
S - Sale -4,102 496,331 -0.82 14.36 -58,886 7,125,030
2017-02-13 3 MGEN MIRAGEN THERAPEUTICS, INC.
Common Stock
3,715,307
2017-02-13 3 MGEN MIRAGEN THERAPEUTICS, INC.
Common Stock
2,608,303
2017-02-13 3 MGEN MIRAGEN THERAPEUTICS, INC.
Common Stock
3,715,307
2017-02-13 3 MGEN MIRAGEN THERAPEUTICS, INC.
Common Stock
2,608,303
2016-10-31 2016-10-29 4 ARRY ARRAY BIOPHARMA INC
Restricted Stock Units
M - Exercise -5,000 0 -100.00
2016-10-31 2016-10-29 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise 5,000 8,585 139.47 5.83 29,150 50,051
2016-10-31 2016-10-27 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
A - Award 25,000 25,000
2016-10-31 2016-10-27 4 ARRY ARRAY BIOPHARMA INC
Restricted Stock Units
A - Award 5,000 5,000
2015-11-02 2015-10-29 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
A - Award 25,000 25,000
2015-11-02 2015-10-29 4 ARRY ARRAY BIOPHARMA INC
Restricted Stock Units
A - Award 5,000 5,000
2015-03-04 2015-03-03 4 ARRY ARRAY BIOPHARMA INC
Stock Option
M - Exercise -20,000 0 -100.00
2015-03-04 2015-03-03 4 ARRY ARRAY BIOPHARMA INC
Stock Option
M - Exercise -20,000 0 -100.00
2015-03-04 2015-03-03 4 ARRY ARRAY BIOPHARMA INC
Stock Option
M - Exercise -15,000 0 -100.00
2015-03-04 2015-03-03 4 ARRY ARRAY BIOPHARMA INC
Stock Option
M - Exercise -15,000 0 -100.00
2015-03-04 2015-03-03 4 ARRY ARRAY BIOPHARMA INC
Common Stock
S - Sale -70,000 3,585 -95.13 8.00 -560,070 28,684
2015-03-04 2015-03-03 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise 20,000 73,585 37.32 2.46 49,200 181,019
2015-03-04 2015-03-03 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise 20,000 53,585 59.55 3.51 70,200 188,083
2015-03-04 2015-03-03 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise 15,000 33,585 80.71 1.74 26,100 58,438
2015-03-04 2015-03-03 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise 15,000 18,585 418.41 3.37 50,550 62,631
2014-10-31 2014-10-30 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
A - Award 25,000 25,000
2013-10-24 2013-10-23 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
A - Award 25,000 25,000
2013-08-01 2013-07-30 4 RALY Rally Software Development Corp
Common Stock
S - Sale -158,445 225,008 -41.32 23.54 -3,729,367 5,296,081
2013-08-01 2013-07-30 4 RALY Rally Software Development Corp
Common Stock
S - Sale -1,171,248 1,663,299 -41.32 23.54 -27,568,016 39,149,568
2013-08-01 2013-07-30 4 RALY Rally Software Development Corp
Common Stock
S - Sale -76,954 109,282 -41.32 23.54 -1,811,289 2,572,203
2013-07-12 2013-07-10 4 RALY Rally Software Development Corp
Warrant to Purchase Common Stock (right to buy)
X - Other -12,207 0 -100.00
2013-07-12 2013-07-10 4 RALY Rally Software Development Corp
Warrant to Purchase Common Stock (right to buy)
X - Other -808 0 -100.00
2013-07-12 2013-07-10 4 RALY Rally Software Development Corp
Common Stock
S - Sale -1,861 2,834,547 -0.07 24.81 -46,164 70,313,773
2013-07-12 2013-07-10 4 RALY Rally Software Development Corp
Common Stock
X - Other 12,207 2,836,408 0.43 3.78 46,142 10,721,622
2013-07-12 2013-07-10 4 RALY Rally Software Development Corp
Common Stock
S - Sale -124 186,236 -0.07 24.81 -3,076 4,619,770
2013-07-12 2013-07-10 4 RALY Rally Software Development Corp
Common Stock
X - Other 808 186,360 0.44 3.78 3,054 704,441
2013-04-18 2013-04-17 4 RALY Rally Software Development Corp
Series E Preferred Stock
C - Conversion -206,459 0 -100.00
2013-04-18 2013-04-17 4 RALY Rally Software Development Corp
Series D Preferred Stock
C - Conversion -176,994 0 -100.00
2013-04-18 2013-04-17 4 RALY Rally Software Development Corp
Warrant to Purchase Common Stock (right to buy)
C - Conversion 12,206 12,206
2013-04-18 2013-04-17 4 RALY Rally Software Development Corp
Warrant to Purchase Series C Preferred Stock (right to buy)
C - Conversion -12,206 0 -100.00
2013-04-18 2013-04-17 4 RALY Rally Software Development Corp
Warrant to Purchase Common Stock (right to buy)
C - Conversion 808 808
2013-04-18 2013-04-17 4 RALY Rally Software Development Corp
Warrant to Purchase Series C Preferred Stock (right to buy)
C - Conversion -808 0 -100.00
2013-04-18 2013-04-17 4 RALY Rally Software Development Corp
Series C Preferred Stock
C - Conversion -638,328 0 -100.00
2013-04-18 2013-04-17 4 RALY Rally Software Development Corp
Series C Preferred Stock
C - Conversion -42,257 0 -100.00
2013-04-18 2013-04-17 4 RALY Rally Software Development Corp
Series B Preferred Stock
C - Conversion -832,948 0 -100.00
2013-04-18 2013-04-17 4 RALY Rally Software Development Corp
Series B Preferred Stock
C - Conversion -55,151 0 -100.00
2013-04-18 2013-04-17 4 RALY Rally Software Development Corp
Series A-1 Preferred Stock
C - Conversion -1,352,925 0 -100.00
2013-04-18 2013-04-17 4 RALY Rally Software Development Corp
Series A-1 Preferred Stock
C - Conversion -88,144 0 -100.00
2013-04-18 2013-04-17 4 RALY Rally Software Development Corp
Common Stock
C - Conversion 383,453 383,453
2013-04-18 2013-04-17 4 RALY Rally Software Development Corp
Common Stock
C - Conversion 2,824,201 2,824,201
2013-04-18 2013-04-17 4 RALY Rally Software Development Corp
Common Stock
C - Conversion 185,552 185,552
2012-10-26 2012-10-24 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
A - Award 20,000 20,000
2012-10-26 2012-08-28 4 ARRY ARRAY BIOPHARMA INC
Common Stock
G - Gift -1,000 3,585 -21.81
2012-04-27 2012-04-25 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
A - Award 25,000 25,000
2012-04-27 2011-12-22 4 ARRY ARRAY BIOPHARMA INC
Common Stock
G - Gift 5,415 30,000 22.03
2012-04-27 2011-12-22 4 ARRY ARRAY BIOPHARMA INC
Common Stock
G - Gift -5,415 4,585 -54.15
2009-04-08 2009-04-06 4 ABIO ARCA biopharma, Inc.
Common Stock
J - Other 31 549 5.98
2009-04-08 2009-04-06 4 ABIO ARCA biopharma, Inc.
Common Stock
J - Other 518 518
2009-04-08 2009-04-06 4 ABIO ARCA biopharma, Inc.
Common Stock
J - Other -3,292 44,715 -6.86
2009-04-08 2009-04-06 4 ABIO ARCA biopharma, Inc.
Common Stock
J - Other -49,708 675,403 -6.86
2009-02-05 3 ABIO ARCA biopharma, Inc.
Common Stock
725,111
2009-02-05 3 ABIO ARCA biopharma, Inc.
Common Stock
48,007
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)